PIMCO Income Strategy Fund/ US72201H1086 /
29/05/2024 22:10:00 | Chg. -0.03 | Volume | Bid02:00:00 | Demandez à02:00:00 | Haut | Bas |
---|---|---|---|---|---|---|
8.26USD | -0.36% | 85,148 Chiffrre d'affaires: 665,052.57 |
8.17Bid taille: 100 | 8.38Ask la taille: 100 | 8.30 | 8.26 |
GlobeNewswire
08:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
08:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
08:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
08:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
GlobeNewswire
08:30
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page